Designing health care organisations for excellence.

J Acad Hosp Adm

Dept. of Hospital Administration, Sher-e-Kashmir Institute of Medical Sciences, Sri Nagar, India.

Published: January 1993

Download full-text PDF

Source

Publication Analysis

Top Keywords

designing health
4
health care
4
care organisations
4
organisations excellence
4
designing
1
care
1
organisations
1
excellence
1

Similar Publications

Background: Patients with chronic kidney disease and their families request early and continuous advance care planning. Based on user involvement, an advance care planning intervention was developed to support patients, family members and healthcare professionals (HCPs) in advance care planning conversations in a nephrology outpatient setting.

Objective: To explore the experiences and perceptions of an advance care planning intervention among patients with chronic kidney disease, family members and healthcare professionals.

View Article and Find Full Text PDF

Objective: To investigate whether differences in early cleft care increase risk of velopharyngeal insufficiency (VPI) after maxillary advancement.

Design: Retrospective cohort study.

Setting: Large pediatric tertiary care hospital.

View Article and Find Full Text PDF

Aims: To translate the Supportive and Palliative Care Indicators Tool (SPICT) into Chinese and conduct preliminarily tests of its performance in hospitalized patients with cancer.

Design: A cross-sectional validation study conducted from January to March 2024.

Methods: SPICT 2022 was translated in both directions, following the Brislin translation model, and the Chinese version culturally debugged through expert consultation and pre-testing.

View Article and Find Full Text PDF

Aim: To explore the perceptions and experiences of students raising concerns during pre-registration health and/or social care training in England.

Design: Systematic review.

Data Sources: MEDLINE, CINAHL, ERIC, PsycINFO and Education Research Complete were systematically searched for studies published between September 2015 and August 2024.

View Article and Find Full Text PDF

In recent years, regulatory authorities have signaled a willingness to consider real-world evidence (RWE) data to support applications for new claims and indications for pharmaceuticals. Historically, RWE studies have been the domain of prescription drugs, driven by the fact that clinical data on patients are routinely captured in medical records, claims databases, registries, etc. However, RWE reports of nonprescription drugs and supplements are relatively sparse due to methodological gaps in this area.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!